Illumina Inc (ILMN)

347.28
-10.20(-2.85%)
After Hours
349.81
+2.53(+0.73%)
- Real-time Data
  • Volume:
    1,125,625
  • Bid/Ask:
    346.72/350.00
  • Day's Range:
    341.03 - 362.49

ILMN Overview

Prev. Close
357.48
Day's Range
341.03-362.49
Revenue
4.28B
Open
360.56
52 wk Range
335.68-555.77
EPS
6.07
Volume
1,125,625
Market Cap
54.28B
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
848,350
P/E Ratio
57.24
Beta
0.9
1-Year Change
-0.96%
Shares Outstanding
156,300,000
Next Earnings Date
01 Feb 2022
What is your sentiment on Illumina Inc?
or
Market is currently closed. Voting is open during market hours.

Illumina Inc Company Profile

Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. The company provides instruments and consumables used in genetic analysis; and genotyping and sequencing services, instrument service contracts, and development and licensing agreements. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. The company markets and distributes its products directly to customers in North America, Europe, Latin America, and the Asia-Pacific region, as well as sells through life-science distributors in various markets within Europe, the Asia-Pacific region, Latin America, the Middle East, and Africa. It has collaboration agreements with Geneseeq Technology Inc. to develop comprehensive in-vitro diagnostic (IVD) NGS testing kits for cancer; LetsGetChecked to track COVID-19 variants in California; and Merck & Co., Inc. to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency. The company was incorporated in 1998 and is headquartered in San Diego, California.

Read More

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyNeutralSellStrong SellNeutral
Technical IndicatorsStrong BuyStrong BuyStrong SellStrong SellStrong Sell
SummaryStrong BuyBuyStrong SellStrong SellSell
  • these guys are *the* DNA sequencing company of the future. they've just won a bunch of patent lawsuits to protect their proprietary technology going forward, have been granted emergency approval by the FDA to help combat Covid and are going to have their machines in half the research labs and universities in the world. I'm excited for how this one will develop over the coming years as biotech booms
    1
    • hi
      0
      • ILLUMINA is going to punch a hole in the sky tonight !!! all the way back to 380‼️ SOON
        0
        Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
        Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.